News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Juno Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Juno Therapeutics was acquired by Bristol-Myers Squibb in 2019.
BioForest
Here’s What Juno Therapeutics Really Thinks About Local Rival Adaptive Biotech
May 29, 2015
·
4 min read
Business
Editas Medicine, Juno Therapeutics Hammer Out $727 Million CAR T R&D Deal
May 27, 2015
·
10 min read
Job Trends
Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees
May 21, 2015
·
4 min read
Deals
White-Hot Juno Therapeutics Goes Shopping Again, Shelling Out $81 Million for Stage Cell Therapeutics
May 11, 2015
·
7 min read
Business
$60 Million Juno Therapeutics Deal Pushes Fate Therapeutics Up 80% in Premarket Trading
May 6, 2015
·
7 min read
Drug Development
CAR-T Cell Companies Juno Therapeutics, Kite Pharma, and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG Trial News
April 21, 2015
·
2 min read
Business
Roaring Juno Therapeutics Ends Quest for New Headquarters and Blueprints Plans to Keep Investors Happy
April 9, 2015
·
2 min read
BioForest
Juno Therapeutics CEO, Arch Co-Founder Say Federal Innovation Act Would “Trash The Next Generation” Of Biotechs
March 26, 2015
·
1 min read
Business
Juno Therapeutics Falls as Company Projects Up to $150 Million Cash Burn in First Post-IPO Earnings Report
March 19, 2015
·
5 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Deals
Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
March 6, 2018
·
2 min read
Deals
Celgene Announces Expiration of Cash Tender Offer for Shares of Juno Therapeutics, Inc.
March 5, 2018
·
3 min read
Deals
Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc.
February 2, 2018
·
5 min read
Business
Juno Taps Former Genentech Exec as CIO
January 5, 2018
·
5 min read
Business
Juno, Thermo Fisher Ink CAR T Manufacturing Partnership
December 20, 2017
·
4 min read
BioForest
Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH
December 12, 2017
·
12 min read
Pharm Country
Juno Therapeutics and Celgene Corporation Release Additional Data From TRANSCEND Trial of JCAR017 in Patients With Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
December 11, 2017
·
9 min read
BioForest
Juno Therapeutics Highlights Key Translational Insights With JCAR017 in Patients With DLBCL
December 9, 2017
·
6 min read
Business
Juno Therapeutics Signs Licensing Agreements With Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma With Gamma Secretase Inhibition
December 6, 2017
·
6 min read
Business
Juno Therapeutics Appoints Ann L. Lee as Executive Vice President of Technical Operations and Patrick Y. Yang as Executive Vice President, Senior Advisor to the CEO
November 27, 2017
·
7 min read
